Clinical Trial Update: Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sphenopalatine ganglion nerve block to amitriptyline (Elavil) for transformed migraines was terminated, with results posted in December …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Daily Headache
• Transformed Migraine

Drugs mentioned

• Elavil (amitriptyline)
• Sphenopalatine ganglion nerve block

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Transformed Migraine, Chronic Daily Headache | Phase 4 | Status: TERMINATED | Results posted: 2021-12-29